To include your compound in the COVID-19 Resource Center, submit it here.

Xenova, KS Biomedix deal

XEN will buy KSB for £8.5 million ($13.6 million) in stock, based on XEN's closing price of 12.25p on

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE